1CM
EXAS

1492 Capital Management’s Exact Sciences EXAS Stock Holding History

1492 Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-31,605
Closed -$1.73M – 123
2025
Q3 		$1.73M Buy
+31,605
New +$1.58M 0.7% 54
2024
Q4 		– Sell
-82,841
Closed -$5.64M – 114
2024
Q3 		$5.64M Sell
82,841
-926
-1% -$52.3K 2.82% 9
2024
Q2 		$3.54M Sell
83,767
-154
-0.2% -$8.47K 2% 19
2024
Q1 		$5.8M Sell
83,921
-233
-0.3% -$14.7K 3.23% 4
2023
Q4 		$6.23M Sell
84,154
-362
-0.4% -$23.7K 3.54% 3
2023
Q3 		$5.77M Buy
84,516
+10,267
+14% +$871K 3.71% 3
2023
Q2 		$6.97M Sell
74,249
-53
-0.1% -$4.13K 4.06% 2
2023
Q1 		$5.04M Buy
74,302
+23,527
+46% +$1.51M 3.11% 6
2022
Q4 		$2.51M Buy
+50,775
New +$2.07M 1.62% 21
2014
Q3 		– Sell
-65,117
Closed -$1.11M – 126
2014
Q2 		$1.11M Sell
65,117
-1,734
-3% -$23.9K 0.57% 47
2014
Q1 		$947K Buy
+66,851
New +$903K 0.47% 57

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

1492 Capital Management's EXAS Position: Q4 2025 in Review

1492 Capital Management sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 31,605 shares — an estimated $1.73M sold.

1492 Capital Management first reported a position in EXAS in Q1 2014 and held it in 11 quarters. The position peaked at $6.97M in Q2 2023. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • 1492 Capital Management reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • 1492 Capital Management sold 31,605 Exact Sciences shares in Q4 2025, an estimated $1.73M.
  • 1492 Capital Management first reported a position in Exact Sciences in Q1 2014 and held it in 11 quarters.
  • 1492 Capital Management's Exact Sciences position peaked at $6.97M in Q2 2023.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on 1492 Capital Management's 13F filing for Q4 2025, filed 10 Feb 2026.